Page last updated: 2024-08-21

dihydroergotamine and Prostatic Neoplasms

dihydroergotamine has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hallwachs, O; Heinz, A; Meyer, WW	1

Trials

1 trial(s) available for dihydroergotamine and Prostatic Neoplasms

Article	Year
[Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy]. Der Urologe. Ausg. A, 1984, Volume: 23, Issue:3 Topics: Aged; Anticoagulants; Antineoplastic Agents; Aspirin; Clinical Trials as Topic; Diethylstilbestrol; Dihydroergotamine; Drug Combinations; Glycine; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Platelet Aggregation; Prostatic Neoplasms; Retrospective Studies; Thromboembolism	1984

Article

Year

[Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy].

Der Urologe. Ausg. A, 1984, Volume: 23, Issue:3

Topics: Aged; Anticoagulants; Antineoplastic Agents; Aspirin; Clinical Trials as Topic; Diethylstilbestrol; Dihydroergotamine; Drug Combinations; Glycine; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Platelet Aggregation; Prostatic Neoplasms; Retrospective Studies; Thromboembolism

1984